Suppr超能文献

结膜和泪囊鳞状细胞癌及前驱病变中高危人乳头瘤病毒的评估

Evaluation for High-risk HPV in Squamous Cell Carcinomas and Precursor Lesions Arising in the Conjunctiva and Lacrimal Sac.

作者信息

Afrogheh Amir H, Jakobiec Frederick A, Hammon Rebecca, Grossniklaus Hans E, Rocco James, Lindeman Neal I, Sadow Peter M, Faquin William C

机构信息

*Pathology Service, Massachusetts General Hospital ‡Department of Ophthalmology, David G. Cogan Laboratory of Ophthalmic Pathology, Massachusetts Eye and Ear Infirmary §Department of Otolaryngology, Massachusetts Eye and Ear Infirmary #Department of Pathology, Brigham and Women's Hospital †Harvard Medical School, Boston, MA ∥Department of Ophthalmology, L.F. Montgomery Laboratory of Ophthalmic Pathology, Emory University, Atlanta, GA ¶Division of Head and Neck Oncologic Surgery, The Ohio State Wexner Medical Center, Columbus, OH.

出版信息

Am J Surg Pathol. 2016 Apr;40(4):519-28. doi: 10.1097/PAS.0000000000000581.

Abstract

High-risk human papilloma virus (HR-HPV) is a well-established causative agent of oropharyngeal squamous cell carcinoma (SCC). In addition, HR-HPV has occasionally been reported to be present in dysplastic and malignant lesions of the conjunctiva and lacrimal sac, although its overall incidence and etiological role in periocular SCC are controversial. Sequential surgical samples of 52 combined cases of invasive SCC (I-SCC) and SCC in situ (SCCIS) from 2 periocular sites (conjunctiva and lacrimal sac) diagnosed over a 14-year period (2000 to 2014) were selected for evaluation, and relevant patient characteristics were documented. p16 immunohistochemistry was performed as a screening test. All p16-positive cases were further evaluated for HR-HPV using DNA in situ hybridization (DNA ISH), and a subset was also analyzed by polymerase chain reaction (PCR). Of 43 ocular surface squamous neoplasias (OSSNs), 30% (n=13; 8 SCCIS and 5 I-SCC cases) were positive for HR-HPV. HPV-positive OSSNs occurred in 8 men and 5 women with a mean age of 60 years (range, 39 to 94 y). HPV type-16 was detected in all conjunctival cases evaluated by PCR. All 5 conjunctival I-SCCs were nonkeratinizing (n=4) or partially keratinizing (n=1) and managed by simple excision. In contrast, HPV-negative conjunctival I-SCCs were predominantly keratinizing (11 keratinizing and 2 nonkeratinizing). Of 9 lacrimal sac I-SCCs (LSSCCs), 66.7% (n=6) were positive for HR-HPV by p16 and DNA ISH; HPV subtypes were HPV-16 (n=5) and HPV-58 (n=1). In addition, 2 p16-positive cases with negative DNA ISH results were HR-HPV positive (HPV-16 and HPV-33) when evaluated by PCR, suggesting that the rate of HR-HPV positivity among the LSSCCs may be as high as 89% (n=8). The combined group of HR-HPV-positive LSSCCs was seen in 4 men and 4 women with a mean age of 60 years (range, 34 to 71 y). Seven of the 8 HPV-positive LSSCCs (87.5%) had a nonkeratinizing or partially keratinizing histomorphology, whereas 1 case (12.5%) was predominantly keratinizing. The presence of HR-HPV in 30% of OSSNs and at least 66.7% of LSSCCs suggests the possibility of an etiologic role for HR-HPV at these sites.

摘要

高危型人乳头瘤病毒(HR-HPV)是口咽鳞状细胞癌(SCC)公认的致病因素。此外,尽管HR-HPV在眼周SCC中的总体发病率和病因学作用存在争议,但偶尔也有报道称其存在于结膜和泪囊的发育异常及恶性病变中。选取了在14年期间(2000年至2014年)诊断的来自2个眼周部位(结膜和泪囊)的52例浸润性SCC(I-SCC)和原位SCC(SCCIS)合并病例的连续手术样本进行评估,并记录了相关患者特征。进行p16免疫组织化学作为筛查试验。所有p16阳性病例均使用DNA原位杂交(DNA ISH)进一步评估HR-HPV,并且还通过聚合酶链反应(PCR)分析了一个子集。在43例眼表鳞状上皮肿瘤(OSSN)中,30%(n = 13;8例SCCIS和5例I-SCC病例)的HR-HPV呈阳性。HPV阳性的OSSN发生在8名男性和5名女性中,平均年龄为60岁(范围39至94岁)。通过PCR评估的所有结膜病例中均检测到HPV-16型。所有5例结膜I-SCC均为非角化型(n = 4)或部分角化型(n = 1),并通过简单切除进行处理。相比之下,HPV阴性的结膜I-SCC主要为角化型(11例角化型和2例非角化型)。在9例泪囊I-SCC(LSSCC)中,通过p16和DNA ISH检测,66.7%(n = 6)的HR-HPV呈阳性;HPV亚型为HPV-16(n = 5)和HPV-58(n = 1)。此外,2例p16阳性但DNA ISH结果为阴性的病例在通过PCR评估时HR-HPV呈阳性(HPV-16和HPV-33),这表明LSSCC中HR-HPV阳性率可能高达89%(n = 8)。HR-HPV阳性的LSSCC合并组见于4名男性和4名女性,平均年龄为60岁(范围34至71岁)。8例HPV阳性的LSSCC中有7例(87.5%)具有非角化或部分角化的组织形态,而1例(12.5%)主要为角化型。30%的OSSN和至少66.7%的LSSCC中存在HR-HPV,这表明HR-HPV在这些部位可能具有病因学作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验